| 000 | 02520 a2200685 4500 | ||
|---|---|---|---|
| 005 | 20250517001952.0 | ||
| 264 | 0 | _c20150730 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.2163 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFalchook, Gerald S | |
| 245 | 0 | 0 |
_aTargeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. _h[electronic resource] |
| 260 |
_bOncotarget _cNov 2014 |
||
| 300 |
_a10280-92 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 |
_aBoronic Acids _xadministration & dosage |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 |
_aFatigue _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 |
_aProteasome Endopeptidase Complex _xdrug effects |
| 650 | 0 | 4 |
_aPyrazines _xadministration & dosage |
| 650 | 0 | 4 |
_aThrombocytopenia _xetiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _ximmunology |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xmetabolism |
| 700 | 1 | _aWheler, Jennifer J | |
| 700 | 1 | _aNaing, Aung | |
| 700 | 1 | _aJackson, Edward F | |
| 700 | 1 | _aJanku, Filip | |
| 700 | 1 | _aHong, David | |
| 700 | 1 | _aNg, Chaan S | |
| 700 | 1 | _aTannir, Nizar M | |
| 700 | 1 | _aLawhorn, Kristie N | |
| 700 | 1 | _aHuang, Mei | |
| 700 | 1 | _aAngelo, Laura S | |
| 700 | 1 | _aVishwamitra, Deeksha | |
| 700 | 1 | _aHess, Kenneth | |
| 700 | 1 | _aHoward, Adrienne N | |
| 700 | 1 | _aParkhurst, Kristin L | |
| 700 | 1 | _aAmin, Hesham M | |
| 700 | 1 | _aKurzrock, Razelle | |
| 773 | 0 |
_tOncotarget _gvol. 5 _gno. 21 _gp. 10280-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.2163 _zAvailable from publisher's website |
| 999 |
_c24332370 _d24332370 |
||